Masahiro Miyake Selected Research

Photochemotherapy (Photodynamic Therapy)

1/2023	Macular atrophy at 5 years after photodynamic therapy for polypoidal choroidal vasculopathy.
1/2023	Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy.
6/2022	Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis.
6/2022	Rescue photodynamic therapy for age-related macular degeneration refractory to anti-vascular endothelial growth factor monotherapy.
12/2019	Efficacy of Photodynamic Therapy for Polypoidal Choroidal Vasculopathy Associated with and without Pachychoroid Phenotypes.
2/2015	Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiro Miyake Research Topics

Disease

25	Macular Degeneration (Age-Related Maculopathy) 01/2024 - 07/2012
12	Glaucoma 01/2024 - 12/2014
12	Polypoidal Choroidal Vasculopathy 01/2024 - 07/2012
11	Myopia 11/2023 - 01/2013
8	Atrophy 11/2023 - 01/2013
6	Choroidal Neovascularization 09/2023 - 04/2012
4	Cataract (Cataracts) 01/2024 - 01/2013
3	Central Serous Chorioretinopathy 01/2023 - 11/2020
3	Retinal Detachment (Retinal Detachments) 01/2022 - 07/2012
2	Hemorrhage 11/2023 - 12/2020
2	Retinal Perforations 11/2023 - 01/2022
2	Atopic Dermatitis (Atopic Eczema) 10/2023 - 01/2021
2	Ganglion Cysts (Ganglion) 01/2015 - 12/2014
1	Corneal Diseases (Corneal Disease) 01/2024
1	Hypoxia (Hypoxemia) 01/2024
1	Obstructive Sleep Apnea 01/2024
1	Fibrosis (Cirrhosis) 11/2023
1	Retinal Arterial Macroaneurysm 11/2023
1	Epiretinal Membrane (Epiretinal Membranes) 07/2023
1	Vitreous Detachment (Posterior Vitreous Detachment) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Cerebral Small Vessel Diseases 01/2022
1	Cognitive Dysfunction 01/2022
1	Blister (Bulla) 12/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Keratoconus 01/2020
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2020
1	Cysts 01/2019
1	Chlamydophila Infections 03/2015
1	Coronary Disease (Coronary Heart Disease) 01/2015
1	Geographic Atrophy 11/2013
1	Papilledema 07/2012
1	Mental Disorders (Mental Disorder) 07/2003

Drug/Important Bio-Agent (IBA)

14	Retinaldehyde (Retinal)IBA 01/2024 - 12/2014
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 04/2012
11	Ranibizumab (Lucentis)FDA Link 11/2023 - 07/2012
9	afliberceptIBA 11/2023 - 11/2014
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023 - 02/2015
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
3	N-acetyltryptophanamide (NATA)IBA 11/2023 - 01/2023
3	ras-GRF1 (ras GRF1)IBA 12/2020 - 11/2013
3	Complement Factor H (Factor H)IBA 11/2019 - 09/2013
2	faricimabIBA 01/2024 - 11/2023
2	SteroidsIBA 10/2023 - 01/2021
2	Ophthalmic Solutions (Eye Drops)IBA 01/2022 - 12/2020
2	Retinal Pigments (Pigments, Visual)IBA 01/2016 - 11/2013
1	AngiopoietinsIBA 11/2023
1	Vascular Endothelial Growth FactorsIBA 11/2023
1	Therapeutic UsesIBA 11/2023
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2023
1	GTP Phosphohydrolases (GTPases)IBA 11/2023
1	Laminin (Merosin)IBA 11/2023
1	Collagen Type IXIBA 11/2023
1	GATA5 Transcription FactorIBA 11/2023
1	CollagenIBA 11/2023
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2023
1	Verteporfin (Visudyne)FDA Link 06/2022
1	AdrenomedullinIBA 01/2022
1	Coffee FDA Link 05/2021
1	Pregnenolone Carbonitrile (PCN)IBA 11/2020
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 12/2019
1	Type II Vasoactive Intestinal Peptide ReceptorsIBA 11/2019
1	P-2 (P 2)IBA 01/2019
1	isopropyl unoprostone (Rescula)FDA Link 03/2017
1	CalciumIBA 03/2015
1	HDL CholesterolIBA 01/2015
1	Retinoic Acid 4-Hydroxylase (CYP26B1)IBA 10/2014
1	Fluorescein (Funduscein)FDA LinkGeneric 08/2014
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 08/2014
1	Proteins (Proteins, Gene)FDA Link 12/2013
1	LipidsIBA 09/2013
1	Cholesterol Ester Transfer ProteinsIBA 09/2013
1	Complement Factor I (C3b Inactivator)IBA 06/2013
1	pigment epithelium-derived factorIBA 06/2013
1	Bevacizumab (Avastin)FDA Link 01/2013
1	Insulin-Like PeptidesIBA 01/2013
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2013
1	Clonazepam (Rivotril)FDA LinkGeneric 07/2003

Therapy/Procedure

7	Therapeutics 06/2022 - 05/2013
7	Intravitreal Injections 12/2021 - 01/2013
6	Photochemotherapy (Photodynamic Therapy) 01/2023 - 02/2015
3	Injections 01/2024 - 01/2019
3	Vitrectomy 11/2023 - 01/2022
3	Trabeculectomy (Trabeculoplasty) 10/2023 - 12/2021
3	Traction 07/2023 - 04/2016
2	Aftercare (After-Treatment) 01/2022 - 07/2012
1	Slit Lamp 01/2024
1	Vitreoretinal Surgery 12/2023
1	Operative Surgical Procedures 10/2023
1	Corneal Transplantation (Keratoplasty) 01/2020